Amani Kitali

473 citations
22 papers · 259 indexed · h-index 11
Topics
Multiple Myeloma Research and Treatments (21 papers)Cancer Treatment and Pharmacology (9 papers)Protein Degradation and Inhibitors (8 papers)
Partner nations
United States

In The Last Decade

Amani Kitali

20 papers receiving 252 citations

Peers

Amani Kitali
Comparison fields: 5 of 36
  • Hematology 245
  • Molecular Biology 193
  • Oncology 171
  • Genetics 25
  • Surgery 9
Replace Paul Schoen with:
Paul Schoen United Kingdom
Kathleen Colson United States
Leah Fink Switzerland
Trisha Piontek United States
Julie Blædel United States
Lela M. Lucy Italy
Joanna Opalińska United States
Robin Carson United States
Margarita Kulakova United States
Kathryn McDonnell United States
Amani Kitali relative to Paul Schoen United Kingdom Paul Schoen's profile →
Citations per field
00.5×1.5×
Paul Schoen · 1×
Citations per year

Countries citing papers authored by Amani Kitali

Since Specialization
Citations

This map shows the geographic impact of Amani Kitali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amani Kitali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amani Kitali more than expected).

Fields of papers citing papers by Amani Kitali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amani Kitali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amani Kitali. The network helps show where Amani Kitali may publish in the future.

Co-authorship network of co-authors of Amani Kitali

This figure shows the co-authorship network connecting the top 25 collaborators of Amani Kitali. A scholar is included among the top collaborators of Amani Kitali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amani Kitali. Amani Kitali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 10
4 7
5 11
6 12
7 11
8 29
9 1
10 10
11 29
12 24
13 1
14 1
15 62
16 2
17 5
18 25
19 10
20 5

About Amani Kitali

Amani Kitali is a scholar working on Hematology, Oncology and Molecular Biology, having authored 22 papers that have together received 259 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (21 papers), Cancer Treatment and Pharmacology (9 papers) and Protein Degradation and Inhibitors (8 papers). The work is most often cited by research in Hematology (245 citations), Oncology (171 citations) and Molecular Biology (193 citations). Amani Kitali has collaborated with scholars based in United States. Frequent co-authors include James W. Hardin, Mohit Narang, Robert M. Rifkin, Kathleen Toomey, Rafat Abonour, Shankar Srinivasan, Howard R. Terebelo, Cristina Gasparetto, Sundar Jagannath and E. Dawn Flick. Their work appears in journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026